Follow
Miklós Képiró
Miklós Képiró
iBar Experience
Verified email at ibar.ai - Homepage
Title
Cited by
Cited by
Year
para‐Nitroblebbistatin, the Non‐Cytotoxic and Photostable Myosin II Inhibitor
M Képiró, BH Várkuti, L Végner, G Vörös, G Hegyi, M Varga, ...
Angewandte Chemie International Edition 53 (31), 8211-8215, 2014
1372014
A highly soluble, non-phototoxic, non-fluorescent blebbistatin derivative
BH Várkuti, M Képiró, IÁ Horváth, L Végner, S Ráti, Á Zsigmond, G Hegyi, ...
Scientific reports 6 (1), 26141, 2016
1242016
Azidoblebbistatin, a photoreactive myosin inhibitor
M Képiró, BH Várkuti, A Bodor, G Hegyi, L Drahos, M Kovács, ...
Proceedings of the National Academy of Sciences 109 (24), 9402-9407, 2012
502012
Identification of natural target proteins indicates functions of a serralysin-type metalloprotease, PrtA, in anti-immune mechanisms
G Felföldi, J Marokházi, M Képiró, I Venekei
Applied and environmental microbiology 75 (10), 3120-3126, 2009
422009
Neuron-based high-content assay and screen for CNS active mitotherapeutics
BH Varkuti, M Kepiro, Z Liu, K Vick, Y Avchalumov, R Pacifico, ...
Science advances 6 (2), eaaw8702, 2020
302020
High-throughput small molecule screen identifies modulators of mitochondrial function in neurons
BH Varkuti, Z Liu, M Kepiro, R Pacifico, Y Gai, T Kamenecka, RL Davis
IScience 23 (3), 2020
142020
Molecular tattoo: subcellular confinement of drug effects
M Képiró, BH Várkuti, AA Rauscher, MSZ Kellermayer, M Varga, ...
Chemistry & biology 22 (4), 548-558, 2015
112015
Effect of allosteric inhibition of non-muscle myosin 2 on its intracellular diffusion
ÁI Horváth, M Gyimesi, BH Várkuti, M Képiró, G Szegvári, I Lőrincz, ...
Scientific Reports 10 (1), 13341, 2020
92020
High content, phenotypic assays and screens for compounds modulating cellular processes in primary neurons
M Kepiro, BH Varkuti, RL Davis
Methods in enzymology 610, 219-250, 2018
92018
Azidation technology: from photoaffinity labeling to molecular tattooing
M Kepiro
PhD Thesis 2014, Eotvos Lorand University, Budapest, Hungary, 2014
52014
Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases
Z Lenkei, AM CSIZMADIA, M Képiró, B Várkuti
US Patent 10,858,357, 2020
22020
Mitotherapeutics for the treatment of brain disorders
RL Davis, Z Liu, BH Varkuti, M Kepiro, CM Macmullen
US Patent App. 17/756,842, 2023
2023
The role of NM2 rearrangement during cytokinesis
AI Horvath, M Gyimesi, M Kepiro, B Varkuti, A Malnasi-Csizmadia
Biophysical Journal 121 (3), 259a-260a, 2022
2022
Molecular Tattoo: Subcellular Confinement of Drug Effects In Vivo with Two-Photon Microscopy
B Várkuti, M Képiró, AÁ Rauscher, L Végner, Á Zsigmond, V Imrich, S Ráti, ...
Biophysical Journal 112 (3), 149a-150a, 2017
2017
Subcellular Spatial Control of Non-Muscle Myosin 2 Redistribution and Stress Fiber Strain by Molecular Tattoo
AI Horvath, BH Varkuti, M Kepiro, G Hegyi, M Kovacs, ...
Biophysical Journal 112 (3), 430a, 2017
2017
Highly Soluble, Non-Phototoxic, Non-Fluorescent, Photostable Blebbistatin Derivatives
AÁ Rauscher, S Kumar, BH Várkuti, M Képiró, ÁI Horváth, L Végner, ...
Biophysical Journal 112 (3), 266a-267a, 2017
2017
Molecular Tattooing of Live Cells and Animals: Spatial and Time Specific Effects of Azidoblebbistatin by Two-Photon Microscopy
M Kepiro, B Varkuti, G Hegyi, MSZ Kellermayer, MC Andras
Biophysical Journal 106 (2), 177a, 2014
2014
Interactomics of Blebbistatin
M Képiró, BH Várkuti, G Hegyi, M Kovács, A Málnási-Csizmadia
Biophysical Journal 104 (2), 403a-404a, 2013
2013
Structural Model of the Pre-Powerstroke State of the Actomyosin Complex
Y Zhenhui, B Varkuti, A Rauscher, M Kepiro, A Malnasi-Csizmadia
Biophysical Journal 102 (3), 16a, 2012
2012
Synthesis and Functional Characterization of Azido-Blebbistatin, a Photoreactive Myosin Inhibitor
M Képiró, BH Várkuti, G Hegyi, M Kovács, A Málnási-Csizmadia
Biophysical Journal 102 (3), 159a, 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–20